U.S. Packaging Stock News

BorgWarner (BWA) has quietly put together an impressive run, with shares up about 42% this year as investors warm to its role in the shift from traditional powertrains to electrified drivetrains. See our latest analysis for BorgWarner. That 42.6% year to date share price return has come as investors steadily reassess BorgWarner’s role in electrification, with the latest move toward 44.66 dollars reinforcing a sense that momentum is still building rather than fading. If you like BorgWarner’s...

Indivior PLC recently reported positive randomized, double-blind clinical trial results showing that both 100-mg and 300-mg monthly maintenance doses of SUBLOCADE® reduced opioid use and supported abstinence in people with moderate-to-severe opioid use disorder, without new safety signals. A key insight from the post-hoc analyses was that the 300-mg monthly dose outperformed the 100-mg dose in participants with high-frequency fentanyl use, underlining SUBLOCADE®’s potential relevance for...

Tech CU recently announced it has partnered with Upstart Holdings to use its AI-powered lending platform, offering personal loans today and planning to add auto refinance loans in early 2026 through the Upstart Referral Network. This partnership highlights how Upstart’s model can plug directly into a credit union’s digital experience, effectively turning Upstart.com traffic into Tech CU-branded loan originations. We’ll now examine how this new Tech CU partnership, which extends Upstart’s...

In December 2025, Invesco and Galaxy Asset Management launched the Invesco Galaxy Solana ETP (QSOL), a Cboe BZX-listed vehicle that offers regulated, spot-based exposure to Solana (SOL) via a grantor trust structure using the Lukka Prime Solana Reference Rate and Coinbase Custody. By adding Solana alongside its existing Bitcoin and Ethereum ETPs and incorporating potential staking income, Invesco is deepening its role as a provider of institutional-grade access to higher-risk digital asset...

DexCom (DXCM) just rolled out Dexcom Academy, a personalised learning platform for healthcare professionals across several EMEA markets, aiming to deepen CGM expertise and quietly reinforce demand for its growing diabetes technology portfolio. See our latest analysis for DexCom. The launch of Dexcom Academy comes at a time when sentiment around DexCom is still resetting. A 30 day share price return of 12.41% has helped to partially offset a year to date share price decline of 16.24% and a...

Regency Centers (REG) has been drifting lower this year, even as its long term track record and cash generation look solid. This raises an interesting question: is the market undervaluing these grocery anchored shopping centers? See our latest analysis for Regency Centers. Even with a recent bounce that left the 1 day share price return at 1.3 percent, Regency Centers is still down on a year to date share price basis, and its multi year total shareholder returns suggest momentum has cooled...

Fifth Third Bancorp (FITB) has quietly outperformed the broader regional bank group this month, and that strength is drawing fresh attention to how its earnings growth and valuation compare at current levels. See our latest analysis for Fifth Third Bancorp. That recent strength comes on top of a solid run, with the share price up about 15.5 percent over the past month and year to date gains supported by a 17.1 percent one year total shareholder return. This suggests momentum is still building...

Granite Construction recently announced that its board declared a quarterly cash dividend of US$0.13 per share, payable on January 15, 2026, to shareholders of record as of December 31, 2025, and the company was awarded an approximately US$24,000,000 contract to upgrade the Perris South Metrolink Station and Layover Facility in Riverside County, California. The Perris South project strengthens Granite’s role in California rail infrastructure while the ongoing cash dividend highlights...

Regeneron Pharmaceuticals (REGN) has caught investors attention after unveiling promising Phase 1/2 data for its multiple myeloma candidate Lynozyfic, along with fresh progress in gene writing and high profile scientific conference appearances. See our latest analysis for Regeneron Pharmaceuticals. Those Lynozyfic results and the new gene writing collaboration have landed against a strong backdrop, with Regeneron’s 90 day share price return of 26.66 percent pointing to building momentum. The...

Aura Minerals Inc. previously upgraded its full-year 2025 production guidance to over 600,000 GEO, up from about 450,000 GEO, reflecting contributions from recent acquisitions and identified expansion projects. The company also released a new feasibility study for the Era Dorada underground gold project in Guatemala, outlining 1.75 million GEO in reserves, first-quartile projected AISC of US$1,178/oz over the mine life, and an after-tax NPV of about US$2.17 billion at very large spot prices...

Century Communities (CCS) has slipped about 1 % over the past week but is still up roughly 9 % this month, leaving investors weighing whether the recent bounce has more room to run. See our latest analysis for Century Communities. Zooming out, the 1 month share price return of 9 % contrasts with a weaker year to date share price performance and a negative 1 year total shareholder return. This suggests recent momentum may be a tentative rebound rather than a firm trend shift. If Century...

Earlier in 2025, Burlington Stores lifted its 2025 net new store outlook to 104 locations and set a goal of at least 110 net new openings in 2026, reinforcing physical expansion as a central growth lever in its off-price retail model. This stepped-up store rollout signals management’s conviction that scaling its brick-and-mortar footprint remains a key driver of long-term operating leverage and market share within value-focused retail. We’ll now examine how Burlington’s higher 2025 and 2026...

Teradata (TDC) shares have quietly outpaced the broader software space over the past 3 months, climbing around 35%, even as the stock is still down over the past year and year to date. See our latest analysis for Teradata. The recent 30 day share price return of 14.35%, and 34.53% over 90 days, suggests momentum is rebuilding after a tougher stretch, even though the 1 year total shareholder return remains slightly negative. If Teradata’s move has you watching software names more closely, this...

Acushnet Holdings (GOLF) just tapped the bond market, issuing $500 million in senior notes to reshape its debt stack, while an insider sale and a bullish post earnings analyst update put the stock under a brighter spotlight. See our latest analysis for Acushnet Holdings. At $83.55, Acushnet’s recent bond deal, steady mid single digit revenue growth, and the FootJoy insider sale are landing against a backdrop of solid momentum, with a roughly mid teens year to date share price return and a...

Elastic and the Cybersecurity and Infrastructure Security Agency (CISA) have partnered with ECS, an ASGN brand, to build and operate a unified SIEM-as-a-Service cybersecurity platform on FedRAMP-certified Elastic Cloud under a U.S. federal contract with an initial value of US$26.0 million and potential total value of up to US$130.0 million over five years. ASGN is pairing this federal cybersecurity win with a rebranding under the “Everforth” master brand and a new US$1.00 billion share...

In recent months, Innodata repositioned itself as a data engineering partner for generative AI, while also launching a new federal business unit targeting U.S. defense and intelligence agencies with an initial engagement expected to generate about US$25,000,000 in revenue. This shift toward higher-value AI services and federal work, alongside improving EBITDA margins and a stronger cash position, marks a meaningful evolution in the company’s business mix and customer base. We’ll now examine...

In recent months, Blue Owl Capital has faced multiple securities class action lawsuits alleging that it misled investors about liquidity pressures tied to redemptions and the planned merger of its business development companies, following weaker-than-expected third-quarter 2025 results and contentious merger terms for OBDC II shareholders. Beyond the legal claims, the controversy has highlighted how liquidity constraints, redemption limits, and potential valuation “haircuts” inside key...

Whirlpool has recently been drawn into the abrupt shutdown and Chapter 11 bankruptcy of Howard's Appliance in Southern California, where the 79-year-old retailer closed all stores, laid off staff, and moved to liquidate assets while carrying US$17.20 million in liabilities, including unpaid taxes and vendor liens that list Whirlpool as a creditor. At the same time, Whirlpool Foundation's backing of The Washing Machine Project's Divya manual washer, named one of TIME's Best Inventions of...

Haemonetics (HAE) just took a hit after Needham cut the stock to Hold, citing rising competition from Abbott and Cordis in vascular closure devices and raising questions about how durable that Interventional Technologies growth story really is. See our latest analysis for Haemonetics. The downgrade comes after a strong run, with a roughly 56% 3 month share price return followed by a 1 week pullback. However, the 5 year total shareholder return remains deeply negative and suggests longer term...

Planet Fitness (PLNT) just reshaped its balance sheet and capital return playbook, closing a $750 million refinancing while simultaneously leaning into share buybacks with a $350 million accelerated repurchase and a fresh $500 million authorization. See our latest analysis for Planet Fitness. Those moves land during a solid upswing, with the 1 month share price return at 7.6 percent and the 3 year total shareholder return above 40 percent. This suggests momentum is quietly rebuilding as...

Zymeworks recently secured FDA approval for its internally developed therapy zanidatamab to treat HER2-positive biliary tract cancer, marking a key regulatory milestone for the company’s oncology portfolio. This approval reinforces Zymeworks’ ability to convert its antibody engineering platforms into commercial-stage assets, an important proof point for its partnership- and royalty-focused business model. We’ll now explore how FDA approval for zanidatamab in HER2-positive biliary tract...

RLJ Lodging Trust (RLJ) has quietly climbed about 6% over the past month even as its year to date return sits deep in the red, setting up an interesting rebound compared with its longer term slump. See our latest analysis for RLJ Lodging Trust. That recent 6% one month share price return is a welcome change of pace for RLJ, but it comes against a still weak year to date share price return and negative multi year total shareholder returns, suggesting momentum is only cautiously rebuilding. If...

Stock Yards Bancorp (SYBT) has quietly slipped around 1% over the past week while still holding a solid gain over the past month, a setup that invites a closer look at valuation and earnings power. See our latest analysis for Stock Yards Bancorp. The recent 1 month share price return of 6.22 percent, despite a softer 90 day share price performance, suggests sentiment is stabilising around Stock Yards Bancorp as investors reassess its earnings resilience and income appeal, especially given its...

Earlier this month, Annaly Capital Management’s board declared a past fourth-quarter 2025 cash dividend of US$0.70 per share, payable on January 30, 2026, to shareholders of record and ex-dividend on December 31, 2025. This reaffirmed payout has sharpened attention on Annaly’s high-yield income profile and its efforts to sustain dividends after prior reductions. With the dividend reaffirmed at US$0.70 per share, we’ll examine how this affects Annaly’s investment narrative around income...